Table 1. Lactoferrin effect on surface marker expression post LPS treatment of CD16+ macrophages.
CD16 | % Positive cells
|
Geometric MFI
|
||
---|---|---|---|---|
LPS | LPS + HLF 10 | LPS | LPS + HLF 10 | |
HLA-A,B,C | 99.46 ± 0.51 | 99.52 ± 0.46 | 49.7 ± 0.83 | 51.83 ± 2.35 |
HLA-DR | 97.73 ± 0.79 | 97.24 ± 0.21 | 10.56 ± 1.68 | 10.49 ± 1.94 |
CD80 | 68.88 ± 25.85 | 63.93 ± 34.75 | 3.48 ± 0.84 | 3.33 ± 1.17 |
CD86 | 92.55 ± 2.49 | 91.13 ± 6.03 | 10.98 ± 1.91 | 10.48 ± 2.79 |
CD40 | 88.86 ± 7.44 | 88.15 ± 11.92 | 11.24 ± 2.43 | 10.34 ± 3.49 |
CD1b | 11.07 ± 2.79 | 9.09 ± 6.59 | 5.41 ± 0.95 | 5.52 ± 1.34 |
CD1c | 1.18 ± 0.49 | 2.23 ± 0.13 | 2.77 ± 0.14 | 2.76 ± 0.24 |